TY - JOUR
T1 - Neuroimaging correlates of narcolepsy with cataplexy
T2 - A systematic review
AU - Wada, Masataka
AU - Mimura, Masaru
AU - Noda, Yoshihiro
AU - Takasu, Shotaro
AU - Plitman, Eric
AU - Honda, Makoto
AU - Natsubori, Akiyo
AU - Ogyu, Kamiyu
AU - Tarumi, Ryosuke
AU - Graff-Guerrero, Ariel
AU - Nakajima, Shinichiro
N1 - Funding Information:
Dr. Mimura has received grants or speaker’s honoraria from Asahi Kasei Pharma, Astellas Pharmaceutical, Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceutical, Meiji-Seika Pharma, Mochida Pharmaceutical, MSD, Novartis Pharma, Otsuka Pharmaceutical, Pfizer, Shionogi, Takeda, Tanabe Mitsubishi Pharma, and Yoshitomi-Yakuhin within 3 years. Dr. Noda receives research grants from Japan Health Foundation, Meiji Yasuda Mental Health Foundation, Mitsui Life Social Welfare Foundation, Takeda Science Foundation, SENSHIN Medical Research Foundation, Health Science Center Foundation, and Daiichi Sankyo Scholarship Donation Program. He receives equipment-in-kind support for an investigator-initiated study from Magventure Inc. Mr. Plitman has received funding from the Vanier Canada Graduate Scholarship, the Ontario Graduate Scholarship, and the Canada Graduate Scholarship—Master’s. Dr. Honda has received grants from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Society for the Promotion of Science (JSPS), research support from Takeda pharmaceutical company and Alfresa Pharma. Dr. Graff-Guerrero has received support from Brain Canada, Canadian Foundation for Innovation, Canadian Institutes of Health Research (CIHR), Ontario Ministry of Health and Long-Term Care, Ontario Ministry of Research and Innovation, the US National Institute of Health (NIH), Ontario Mental Health Foundation (OMHF), Consejo Nacional de Ciencia y Tecnologia (CONACyT), Instituto de Ciencia y Tecnología del DF (ICyTDF), and Brain & Behavior Research Foundation. Dr. Nakajima has received fellowship grants from Canadian Institute of Health Research (CIHR), research support from Japan Society for the Promotion of Science, Japan Research Foundation for Clinical Pharmacology, Naito Foundation, Takeda Science Foundation, Daiichi Sankyo, and manuscript fees or speaker’s honoraria from Dainippon Sumitomo Pharma and Yoshitomi Yakuhin within the past three years. Other authors have no financial or other relationship relevant to the subject of this manuscript.
Publisher Copyright:
© 2018 Elsevier B.V. and Japan Neuroscience Society
PY - 2019/5
Y1 - 2019/5
N2 - Recent developments in neuroimaging techniques have advanced our understanding of biological mechanisms underpinning narcolepsy. We used MEDLINE to retrieve neuroimaging studies to compare patients with narcolepsy and healthy controls. Thirty-seven studies were identified and demonstrated several replicated abnormalities: (1) gray matter reductions in superior frontal, superior and inferior temporal, and middle occipital gyri, hypothalamus, amygdala, insula, hippocampus, cingulate cortex, thalamus, and nucleus accumbens, (2) decreased fractional anisotropy in white matter of fronto-orbital and cingulate area, (3) reduced brain metabolism or cerebral blood flow in middle and superior frontal, and cingulate cortex (4) increased activity in inferior frontal gyri, insula, amygdala, and nucleus accumbens, and (5) N-acetylaspartate/creatine-phosphocreatine level reduction in hypothalamus. In conclusion, all the replicated findings are still controversial due to the limitations such as heterogeneity or size of the samples and lack of multimodal imaging or follow-up. Thus, future neuroimaging studies should employ multimodal imaging methods in a large sample size of patients with narcolepsy and consider age, duration of disease, age at onset, severity, human leukocyte antigen type, cerebrospinal fluid hypocretin levels, and medication intake in order to elucidate possible neuroimaging characteristic of narcolepsy and identify therapeutic targets.
AB - Recent developments in neuroimaging techniques have advanced our understanding of biological mechanisms underpinning narcolepsy. We used MEDLINE to retrieve neuroimaging studies to compare patients with narcolepsy and healthy controls. Thirty-seven studies were identified and demonstrated several replicated abnormalities: (1) gray matter reductions in superior frontal, superior and inferior temporal, and middle occipital gyri, hypothalamus, amygdala, insula, hippocampus, cingulate cortex, thalamus, and nucleus accumbens, (2) decreased fractional anisotropy in white matter of fronto-orbital and cingulate area, (3) reduced brain metabolism or cerebral blood flow in middle and superior frontal, and cingulate cortex (4) increased activity in inferior frontal gyri, insula, amygdala, and nucleus accumbens, and (5) N-acetylaspartate/creatine-phosphocreatine level reduction in hypothalamus. In conclusion, all the replicated findings are still controversial due to the limitations such as heterogeneity or size of the samples and lack of multimodal imaging or follow-up. Thus, future neuroimaging studies should employ multimodal imaging methods in a large sample size of patients with narcolepsy and consider age, duration of disease, age at onset, severity, human leukocyte antigen type, cerebrospinal fluid hypocretin levels, and medication intake in order to elucidate possible neuroimaging characteristic of narcolepsy and identify therapeutic targets.
KW - Diffusion tensor imaging (DTI)
KW - Magnetic resonance imaging (MRI)
KW - Positron emission tomography (PET)
KW - Proton magnetic resonance spectroscopy ( H-MRS)
KW - Single photon emission computed tomography (SPECT)
KW - Voxel-based morphometry (VBM)
UR - http://www.scopus.com/inward/record.url?scp=85044525692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044525692&partnerID=8YFLogxK
U2 - 10.1016/j.neures.2018.03.005
DO - 10.1016/j.neures.2018.03.005
M3 - Review article
C2 - 29580887
AN - SCOPUS:85044525692
SN - 0168-0102
VL - 142
SP - 16
EP - 29
JO - Neuroscience Research
JF - Neuroscience Research
ER -